Overview

Acarbose and Secondary Prevention After Coronary Stenting

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether the intervention for newly diagnosed abnormal glucose tolerance after coronary stenting will improve the long-term clinical outcome.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Translational Research Informatics Center, Kobe, Hyogo, Japan
Collaborators:
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan
Kobe City General Hospital
Treatments:
Acarbose
Criteria
Inclusion Criteria:

- Within 8 weeks since implantation of coronary artery stents for stable angina pectoris
or acute coronary syndrome.

- Abnormal glucose tolerance according to a 75 g oral glucose tolerance test (OGTT).

- HbA1c is less than 6.5%.

- Age is between 20 and 75 years (at time of consent).

- Patients who can give informed consent themselves in writing.

Exclusion Criteria:

- Patients with abnormal glucose tolerance caused by other organic disorders such as
pancreatitis, hemochromatosis, post pancreatectomy, hyperthyroidism, Cushing syndrome,
Prader-Willi syndrome, etc.

- Patients with planned angioplasty.

- Patients with uncontrollable congestive heart failure.

- Less than 6 months since last episode of cerebral infarction.

- Patients who have received medication for diabetes mellitus before.

- AST (GOT) exceeding 100 IU/L or ALT (GPT) exceeding 100 IU/L.

- Creatinine exceeding 2 mg/dl.

- Patients with a history of ileus or less than 6 months since celiotomy.

- Pregnant women or those who plan to become pregnant, or are in the lactation period.

- Habitual drinker (more than 100 ml/day of alcohol).

- Patients with a history of gastrectomy.

- Patients for whom it is impossible to follow up for 5 years.

- Any other reason that the clinical supervisors or clinical researchers may have for
considering a case unsuitable for the study.